Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Lignende værker

• Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial
  af: Javier Briones, et al.
  Udgivet: (2014-07-01)
• Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
  af: McKinney MS, et al.
  Udgivet: (2014-08-01)
• Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan
  af: Shinobu Tamura, et al.
  Udgivet: (2013-01-01)
• Ibritumomab tiuxetan plus BEAM in refractory diffuse large B-cell lymphoma
  af: Vít Procházka, et al.
  Udgivet: (2014-07-01)
• 90Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates
  af: Zsolt Szakács, MD, PhD, et al.
  Udgivet: (2022-09-01)